Management of Nighttime Heartburn

Immediate Non-Pharmacologic Interventions

Elevating the head of the bed by 6-8 inches is recommended by the American Gastroenterological Association for patients with nighttime heartburn or regurgitation, as it reduces esophageal acid exposure time and improves acid clearance 1, 2, 3
Avoid lying down for 2-3 hours after meals to reduce esophageal acid exposure, as recommended by the American College of Gastroenterology 1, 2
Sleeping in the left lateral decubitus position may be considered as an adjunct measure to reduce reflux episodes, according to the American Gastroenterological Association 4

The American College of Gastroenterology recommends starting with once-daily PPI therapy taken 30-60 minutes before a meal for 4-8 weeks, as PPIs are superior to H2-receptor antagonists and placebo for treating esophageal GERD syndromes 1, 3
If nighttime symptoms persist on once-daily PPI, the American Gastroenterological Association recommends escalating to twice-daily dosing, as most clinical trial data comes from once-daily dosing studies, but expert consensus unanimously recommends twice-daily dosing for patients with unsatisfactory response to once-daily therapy 3
The American College of Gastroenterology does not recommend adding a nocturnal H2-receptor antagonist to twice-daily PPI therapy, as there is no evidence of improved efficacy with this combination 3

The American Heart Association notes that weight loss is the single most effective lifestyle intervention with proven benefit on esophageal pH profiles and symptoms, and should be recommended for all overweight or obese patients with GERD 1, 2, 3

The American Gastroenterological Association recommends avoiding specific trigger foods that consistently provoke symptoms, such as alcohol, coffee, chocolate, fatty foods, spicy foods, citrus, and tomato products 3, 4, 2
Individualized dietary avoidance may be beneficial for patients who consistently experience troublesome heartburn after specific foods, according to the American Gastroenterological Association 3

The American College of Gastroenterology recommends continuing PPI indefinitely for patients with erosive esophagitis or severe GERD phenotype 1
For patients without erosive esophagitis at baseline, the American Gastroenterological Association recommends titrating to the lowest effective PPI dose or considering on-demand therapy with H2-blockers/antacids once symptoms are controlled 1

The American Gastroenterological Association recommends considering endoscopy for patients with troublesome dysphagia, with biopsies targeting any areas of suspected metaplasia or dysplasia 3
Patients who fail twice-daily PPI therapy warrant diagnostic evaluation rather than further empirical treatment escalation, according to the American Gastroenterological Association 3